{"id":{"repo_id":"etsu","oai_identifier":"oai:dc.etsu.edu:etd-5921"},"canonical_url":"https://search.ndltd.org/etd/etsu/oai:dc.etsu.edu:etd-5921","repository":{"repo_id":"etsu","name":"East Tennessee State University","base_url":"https://dc.etsu.edu/do/oai/"},"display":{"title":"Perinatal Buprenorphine Effects on Offspring Growth, Opioid Withdrawal, and Brain Morphology in Rats","abstract":"Opioid use disorder (OUD) impacts 5.6 million people in the US. Buprenorphine (BUP) is a commonly prescribed opioid medication used to treat OUD, including in pregnant women. However, opioid use during pregnancy is associated with poorer infant outcomes including reduced fetal growth, neurodevelopmental deficits, and neonatal opioid withdrawal syndrome (NOWS). Recent clinical data suggests that providing mothers with a lower dose of BUP may result in fewer negative outcomes in infants. Here, a preclinical rodent model of low-dose perinatal BUP exposure was used to study offspring health outcomes in the neonate, juvenile, and adolescent offspring. Dams were given clinically relevant doses of BUP prior to and throughout gestation, and continuing through weaning to mimic human doses and exposure. Although the lowest BUP dose still elicited signs of NOWS in offspring, there were fewer negative effects on overall brain morphology across the early lifespan than that of the higher BUP dose compared to controls.","abstract_html":"Opioid use disorder (OUD) impacts 5.6 million people in the US. Buprenorphine (BUP) is a commonly prescribed opioid medication used to treat OUD, including in pregnant women. However, opioid use during pregnancy is associated with poorer infant outcomes including reduced fetal growth, neurodevelopmental deficits, and neonatal opioid withdrawal syndrome (NOWS). Recent clinical data suggests that providing mothers with a lower dose of BUP may result in fewer negative outcomes in infants. Here, a preclinical rodent model of low-dose perinatal BUP exposure was used to study offspring health outcomes in the neonate, juvenile, and adolescent offspring. Dams were given clinically relevant doses of BUP prior to and throughout gestation, and continuing through weaning to mimic human doses and exposure. Although the lowest BUP dose still elicited signs of NOWS in offspring, there were fewer negative effects on overall brain morphology across the early lifespan than that of the higher BUP dose compared to controls.","abstract_has_math":false,"creators":["Barnes, Parker"],"institution":"East Tennessee State University","degree_name":"MS (Master of Science)","degree_level":"Thesis - unrestricted","degree_discipline":"Biology","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-05-01T07:00:00Z","date_published":"2024-05-01T07:00:00Z","updated_at":"2026-11-19T07:57:02Z","subjects":["buprenorphine","opioid use disorder","neonatal opioid withdrawal syndrome","Animals","Behavioral Neurobiology","Developmental Neuroscience","Maternal and Child Health","Medical Neurobiology","Neuroscience and Neurobiology","Neurosciences","Obstetrics and Gynecology","Organisms","Public Health"],"languages":["eng"],"rights":["Copyright by the authors."],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dc.etsu.edu/etd/4395","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dc.etsu.edu/etd/4395","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":"https://dc.etsu.edu/context/etd/article/5921/viewcontent/BarnesP042424f.pdf","download_label":"Download PDF","download_source":"dc:identifier","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dc.etsu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adc.etsu.edu%3Aetd-5921","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Barnes, Parker"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-04-01T07:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2024-05-01T07:00:00Z"]},{"key":"dc:publisher","label":"Institution","values":["East Tennessee State University"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis - unrestricted"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS (Master of Science)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["East Tennessee State University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["buprenorphine","opioid use disorder","neonatal opioid withdrawal syndrome","Animals","Behavioral Neurobiology","Developmental Neuroscience","Maternal and Child Health","Medical Neurobiology","Neuroscience and Neurobiology","Neurosciences","Obstetrics and Gynecology","Organisms","Public Health"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright by the authors."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dc.etsu.edu/context/etd/article/5921/viewcontent/BarnesP042424f.pdf","https://dc.etsu.edu/etd/4395"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Opioid use disorder (OUD) impacts 5.6 million people in the US. Buprenorphine (BUP) is a commonly prescribed opioid medication used to treat OUD, including in pregnant women. However, opioid use during pregnancy is associated with poorer infant outcomes including reduced fetal growth, neurodevelopmental deficits, and neonatal opioid withdrawal syndrome (NOWS). Recent clinical data suggests that providing mothers with a lower dose of BUP may result in fewer negative outcomes in infants. Here, a preclinical rodent model of low-dose perinatal BUP exposure was used to study offspring health outcomes in the neonate, juvenile, and adolescent offspring. Dams were given clinically relevant doses of BUP prior to and throughout gestation, and continuing through weaning to mimic human doses and exposure. Although the lowest BUP dose still elicited signs of NOWS in offspring, there were fewer negative effects on overall brain morphology across the early lifespan than that of the higher BUP dose compared to controls."]},{"key":"dc:title","label":"Title","values":["Perinatal Buprenorphine Effects on Offspring Growth, Opioid Withdrawal, and Brain Morphology in Rats"]}]}],"canonical_facts":{"dc:creator":["Barnes, Parker"],"dc:date.available":["2024-04-01T07:00:00Z"],"dc:date.issued":["2024-05-01T07:00:00Z"],"dc:description.abstract":["Opioid use disorder (OUD) impacts 5.6 million people in the US. Buprenorphine (BUP) is a commonly prescribed opioid medication used to treat OUD, including in pregnant women. However, opioid use during pregnancy is associated with poorer infant outcomes including reduced fetal growth, neurodevelopmental deficits, and neonatal opioid withdrawal syndrome (NOWS). Recent clinical data suggests that providing mothers with a lower dose of BUP may result in fewer negative outcomes in infants. Here, a preclinical rodent model of low-dose perinatal BUP exposure was used to study offspring health outcomes in the neonate, juvenile, and adolescent offspring. Dams were given clinically relevant doses of BUP prior to and throughout gestation, and continuing through weaning to mimic human doses and exposure. Although the lowest BUP dose still elicited signs of NOWS in offspring, there were fewer negative effects on overall brain morphology across the early lifespan than that of the higher BUP dose compared to controls."],"dc:identifier":["https://dc.etsu.edu/context/etd/article/5921/viewcontent/BarnesP042424f.pdf","https://dc.etsu.edu/etd/4395"],"dc:language":["eng"],"dc:publisher":["East Tennessee State University"],"dc:rights":["Copyright by the authors."],"dc:subject":["buprenorphine","opioid use disorder","neonatal opioid withdrawal syndrome","Animals","Behavioral Neurobiology","Developmental Neuroscience","Maternal and Child Health","Medical Neurobiology","Neuroscience and Neurobiology","Neurosciences","Obstetrics and Gynecology","Organisms","Public Health"],"dc:title":["Perinatal Buprenorphine Effects on Offspring Growth, Opioid Withdrawal, and Brain Morphology in Rats"],"thesis:degree_discipline":["Biology"],"thesis:degree_level":["Thesis - unrestricted"],"thesis:degree_name":["MS (Master of Science)"],"thesis:institution_name":["East Tennessee State University"]},"updated_at":"2026-11-19T07:57:02Z"}